BioStrand's Work Exemplifies the IPA Family's Investment in Advanced AI, Aiding Partners in Developing New Biologics for Previously Undruggable Targets

IPA's Subsidiary, BioStrand, Provides an Update on LENSai(TM)

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) ("ImmunoPrecise" or "IPA" or the "Company"), an AI-driven biotherapeutic research and technology company, announces that its subsidiary, BioStrand®, has commercially launched its state-of-the-art Retrieval Augmented Generation (RAG)-based Large Language Model (LLM) platform.

IPA’s Subsidiary, BioStrand, Provides an Update on LENSai™

LENSai is the company’s latest contribution to the biotech field. The unique feature of LENSai is its ability to connect the fundamental pillars of the biosphere into one comprehensive framework. These pillars consist of sequence, structure and function ...

Overcoming The Information Integration Dilemma: Revolutionizing The Fusion Of Complex Biological Data

Lastly, we are thrilled to introduce a groundbreaking feature in our LENSai platform. Now boasting a cutting-edge combination of our proprietary neuro-symbolic engine and advanced large language ...

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q1 2024 Earnings Call Transcript

Good morning, ladies and gentlemen. Thank you for joining us today for IPA's Earnings Call covering the First Quarter of Fiscal Year 2024. I am Julianne, and I have the privilege of hosting this ...

ImmunoPrecise Antibodies Ltd. (IPA) Q1 2024 Earnings Call Transcript

The build-out of our LENSai software has been a massive undertaking as it forms the backbone of our operations tying together wet-lab services, software capabilities and our HYFT technology.

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q4 2023 Earnings Call Transcript

And so, they are still asking about using LENSai for analytical insights. They are still asking about de novo in silico work and collaborations, but those all can happen in separate programs that ...

The ongoing advancements in software development, including LENSai software, have enabled IPA to solve real-life biological problems and overcome the challenges of omics data integration and analysis. IPA has strategically positioned itself to capture ...

ImmunoPrecise Reports Financial Results and Recent Business Highlights for Full Fiscal Year 2023

The Company achieved revenue of $20.7 million during the year ended April 30, 2023, a 6.7% increase from the year ended April 30, 2022. YoY growth increases to 9.0% when adjusting for the effects of currency translation. The Company recorded total revenue ...

The Company achieved revenue of $20.7 million during the year ended April 30, 2023, a 6.7% increase from the year ended April 30, 2022. YoY growth increases to 9.0% when adjusting for the effects ...

LensAI

A discussion on LensAI case studies and contextual targeting.

LensAI: Cookie-Busting Ads, Statistics, & Case Studies

An interview with Pavel Shkliaev, CEO of LensAI, who discusses the vision behind the founding of his company and how he measures the company's success.

Startup Interview with Pavel Shkliaev, CEO Of LensAI

LensAI is an AI-powered contextual computer vision ad solution that monetizes any visual content and fine-tunes targeting through identifying objects, and logos

Introducing LensAI: Our Hearts Demand Changes

"Association in psychology refers to a mental connection between concepts, events, or mental states that usually stems from specific experiences." [1] Once the associative link between events A and B has been built, the appearance of event A naturally entails the appearance of event B. [2]

LensAI: Associative Advertising as An Inevitable Evil

Have you heard or perhaps even tried new ways to purchase stuff you see on TV? You know, the ones that invite you to buy things you see while your favorite show is being aired? They offer you to shop through various user interaction mechanics that range from scanning a QR code shown at the corner of the TV screen to pressing a set of navigation buttons on the remote control to receive a text message with a link to the product. What a maze, I have to say. 

Our Quest To Solve Inefficient Web Traffic Monetization

Wikipedia characterizes ADHD symptoms as "difficulty paying attention, excessive activity, and acting without regards to consequences." [1]

As we all live in times when not only new generations, but older ones are prone to the syndrome, how to promote and make money on online advertising? 

Online Advertising in The Time of The Consumer Attention Deficit Hyperactivity Syndrome (ADHD)

The idea of LensAI was born last year sometime in May. If you've missed Part I of my story, you can read it here ->  How We Taught Artificial Intelligence to Sell.

LENSAI

lens-ai.comcontacts.html

employees

Since n.d.

COMPANY RANKING

LENSAI

EVERGREEN INDEX #2749

Representing this company? Click here to claim and customize this page!

Read More Tech Stories Related to #LensAI

LensAI WIKI

Apply to get your Tech Company News Page live on HackerNoon.com today!

LENSAI

lens-ai.comcontacts.html

employees

Since n.d.

COMPANY RANKING

LENSAI

EVERGREEN INDEX #2749

RELATED COMPANIESRANK

HACKERNOON STORIES ON LENSAI

Representing this company? Click here to claim and customize this page!

Read More Tech Stories Related to #LensAI

LensAI WIKI

Apply to get your Tech Company News Page live on HackerNoon.com today!